Topic：Transmembrane targeting peptides as novel anti-cancer agents

Reporter：Dominique BAGNARD, PhD

Time：2015.9.24 10:00AM

Location: Meeting Room, Institute of Neuroscience, Soochow University

Introduction of reporter:

EDUCATION AND TRAINING

1995-1996: Master of Neurosciences (University 5th year)

University Claude Bernard, Lyon I, France.

1996-1999: PhD in Neurosciences under the supervision of Pr. Dr. J. Bolz (INSERM U371 “Brain and Vision” University Claude Bernard Lyon 1 France and Max Planck Institüt Frankfurt, Germany (Dir: AW Püschel)

1999-2000 Postdoc position - Neurobiotec (Neurological Hospital, Lyon)

2004- Research Habilitation. INSERM U575 (Physiopathology of the nervous system). University of Strasbourg, France

MAJOR ACHIEVEMENTS

Assistant Professor; chair of the Molecular and Cellular Neurobiology program of the University of Strasbourg

- Nominated member of the National Council of Universities (Neurosciences section, 2003-2011)

- National and International prizes: best scientific contribution at the 2003 Roche meeting for leading Bioscientists of the next Decade, 2008 Prize of the French foundation for Medical Research (FRM)- Rotary International, 2011 International prize for biomedical innovation “Universal Biotech”)

- Guest editor for Current Pharmaceutical Design (2005-2007)

- Founder and Editor in chief of Cell Adhesion and Migration (ISI, Scopus, Pub Med indexed international peer reviewed journal; 2013 IF: 3.4)

- Authors and co-authors of 55 research papers, reviews, editorials or books (ISI source)

- Co-founder of the startup company Mimesis Pharma (2014)